Pharmanomics: How Big Pharma Destroys Global Health

Pharmanomics investigates how Big Pharma prioritizes profit over health, leading to catastrophic consequences during the Covid pandemic. It reveals a long history of financializing medicine, with companies gouging billions from governments and abandoning the Global South. Big Pharma has protected its property through the patent system, focusing on monopolies rather than research. This system has reshaped the relationship between richer and poorer countries, and Dearden offers a pathway to a fairer, safer system for all.

Format: Hardback
Length: 336 pages
Publication date: 03 October 2023
Publisher: Verso Books

In his groundbreaking book "Pharmanomics," investigative journalist Nick Dearden delves deep into the intricate processes involved in drug production, revealing a shocking truth: Big Pharma is failing us, with catastrophic consequences. The pharmaceutical industry, driven by its pursuit of profit rather than health, has come under intense scrutiny as governments rushed to produce vaccines during the COVID-19 pandemic. Behind the façade of scientific breakthroughs, major companies have exploited loopholes to gouge billions from governments in the West, while abandoning the Global South. This is just the latest episode in a long history of financialization of medicine, marked by Purdue's ruthless marketing of OxyContin, Martin Shkreli's controversial price hike of a lifesaving drug, and the unnecessary deprivation of HIV/AIDS medication for 4.5 million South Africans.

Since the 1990s, Big Pharma has employed the patent system to safeguard its interests, resulting in a shift away from research and development of new medicines toward the establishment of monopolies. This system has fundamentally altered the relationship between richer and poorer countries, as access to new medicines and the permission to manufacture them are tightly controlled. In response to this crisis, Dearden presents a comprehensive roadmap for a fairer, safer system that prioritizes the well-being of patients and the global community.

One of the critical issues highlighted in "Pharmanomics" is the lack of transparency and accountability in the pharmaceutical industry. Companies often prioritize profits over patient safety, engaging in practices such as price gouging and marketing tactics that exploit vulnerable populations. The book exposes the cozy relationships between Big Pharma and regulatory bodies, which fail to hold companies accountable for their actions.

Dearden also criticizes the patent system, arguing that it has created a barrier to innovation and access to medicine. The patent system grants exclusive rights to companies for a limited period, preventing others from manufacturing and selling generic versions of drugs at lower prices. This not only drives up healthcare costs for individuals and governments but also hinders the development of new medicines in developing countries.

To address these challenges, Dearden proposes a range of solutions. He advocates for increased regulation of the pharmaceutical industry, including stricter guidelines for drug approval, greater transparency in pricing and marketing practices, and the promotion of competition among drug manufacturers. He also calls for the development of alternative models of drug production and distribution, such as open-source medicine and community-based healthcare systems.

Furthermore, "Pharmanomics" highlights the importance of public education and awareness about the pharmaceutical industry. Dearden argues that patients should have access to comprehensive information about their medications, including potential side effects and alternative treatment options. He also advocates for greater patient involvement in decision-making processes regarding their healthcare, including the right to participate in clinical trials and access to personalized medicine.

In conclusion, "Pharmanomics" is a powerful and eye-opening book that sheds light on the dark underbelly of the pharmaceutical industry. By exposing the greed and corruption that drive Big Pharma, Dearden provides a roadmap for a fairer, safer system that prioritizes the well-being of patients and the global community. It is a must-read for anyone interested in understanding the complex dynamics of the healthcare industry and the urgent need for change.

Weight: 496g
Dimension: 242 x 161 x 27 (mm)
ISBN-13: 9781804291450